Bruker Reports Third Quarter 2019 Financial Results

– Q3-19 revenue growth of 11.7% and organic revenue growth of 7.6% year-over-year BILLERICA, Mass., Oct. 31, 2019 /PRNewswire/ — Bruker Corporation (Nasdaq: BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2019. Third Quarter 2019 Financial Results Bruker’s revenues for the third quarter of 2019 were $521.1... Read more

PerkinElmer Announces Financial Results for the Third Quarter of 2019

Revenue of $706.9 million; 5% Reported growth; Organic growth of 5% GAAP EPS from continuing operations of $0.53; Adjusted EPS of $1.06 GAAP operating income margin from continuing operations of 11.1%; Adjusted operating income margin from continuing operations of 21.6% Acquisition of Meizheng Group, a food safety testing provider; bolsters assay capabilities in China Adjusting... Read more

Danaher Reports Third Quarter 2019 Results

WASHINGTON, Oct. 24, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced results for the third quarter 2019. For the quarter ended September 27, 2019, net earnings attributable to Danaher common stockholders were $648.4 million, or $0.89 per diluted share which represents a 4.5% year-over-year decrease from the comparable 2018 period. Non-GAAP adjusted diluted net earnings... Read more

GE Healthcare opens lab for life science start-ups at Alderley Park, United Kingdom

Lab will support acceleration of biotechnology, health and life sciences research in the UK Companies to gain access to fully-equipped lab with the latest GE Healthcare Life Sciences technologies Cheshire, United Kingdom, 23 October 2019 – GE Healthcare Life Sciences will inaugurate an open-access lab at Alderley Park’s Mereside Campus, the UK’s largest single-site life... Read more

Tony Hyman Receives Carl Zeiss Lecture 2019

Understanding the mechanisms of cell division This year’s awardee of the Carl Zeiss Lecture, the most visible prize of the German Society for Cell Biology (DGZ), is Anthony A. Hyman, director at the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) in Dresden. At the MPI-CBG 500 curiosity-driven scientists from over 50 countries do pioneering basic... Read more

Luminex Corporation to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

AUSTIN, Texas, Sept. 3, 2019 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Morgan Stanley 17th Annual Global Healthcare Conference to be held September 9-11, 2019, in New York, NY. The fireside chat will begin at 2:05 p.m. Eastern... Read more

BD Announces Results For 2019 Third Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

FRANKLIN LAKES, N.J., Aug. 6, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.350 billion for the third fiscal quarter ended June 30, 2019.  This represents an increase of 1.7 percent over the prior-year period.  On a comparable, currency-neutral basis, revenues increased 5.7 percent... Read more

Consolidated Financial Statements for the First Quarter Ended June 30, 2019 FY2020 (April 1, 2019 – March 31, 2020)[UNAUDITED]

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more